The bill, introduced by Sens. Rick Scott and Kirsten Gillibrand, follows a bipartisan investigation that cited ProPublica’s ...

Is AstraZeneca on track to meet 2030 revenue target?; CSL CEO Paul McKenzie retires; Epstein files reveal deeper ties to ...

Moderna received a surprise refusal from the FDA to review its updated flu vaccine, highlighting the ongoing struggle between vaccine makers and a vaccine-skeptical HHS.

After spending the past few years centering its Beauty on Your Terms campaign around celebrities, Merz is now positioning the brand around everyday consumers.

The Trump administration’s move to give deportation officials access to Medicaid data is putting hospitals and states in a bind as they weigh whether to alert immigrant patients that their personal ...

Diamonds symbolize 60th anniversaries, and MM+M is drawing inspiration from their origin: brilliance forged in the crucible of pressure. This year, we will celebrate industry triumphs tempered by fire ...

Since her first foray on the app in September, MacDonald has used Care Connect at least three more times. Two of those ...

MM+M’s Agency 100 has long been pharma’s definitive guide of healthcare advertising agencies. New technologies, a ...

Ashley Woerner, SVP of account services at Synapse, adds that Rhapsido gained wider recognition as a brand thanks to the ...

Health — pharma included — is no longer operating at the margins of culture. It’s stepping confidently into the center of it.

Novartis CEO Vas Narasimhan received $32.4 million in total realized compensation in 2025, a marked increase compared to his take home pay in 2024. Narasimhan received 24.9 million Swiss Francs last ...

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...